Manchester’s Yourgene confirms £34m Covid contract

Manchester-based molecular diagnostics firm Yourgene Health plc said on Friday that it has been awarded a £34.1 million contract from the UK government to support Covid-19 surge testing.

“Yourgene … announces that a Contract Award Notice has been published in relation to its contract with the Department of Health & Social Care (DHSC) for the provision of laboratory capacity to the NHS Test and Trace Programme for COVID-19 testing, as announced on 19 August 2021 …

“As previously announced, the contract is the first to come from the National Microbiology Framework Lot wins announced earlier this year, using Yourgene’s high throughput automated COVID-19 services testing laboratory in Citylabs 1.0, Manchester.

The final contract notice value of £34m is the maximum estimated value of the contract.

“Actual value will depend on services purchased and there is no committed spend under the contract.

“However, the company confirms that samples are already being processed as part of the contract.

“Yourgene will provide an update for shareholders on first half trading on the morning of the Annual General Meeting due to take place on Tuesday 28 September 2021.”



About the Author

Mark McSherry
Dalriada Media LLC sites are edited by veteran news journalist Mark McSherry, a former staff editor and reporter with Reuters, Bloomberg and major newspapers including the South China Morning Post, London's Sunday Times and The Scotsman. McSherry's journalism has also appeared in The Washington Post, The Guardian, The Independent, The New York Times, London's Evening Standard and Forbes. McSherry is also a professor of journalism and communication arts in universities and colleges in New York City. Scottish-born McSherry has an MBA from the University of Edinburgh and a Certificate in Global Affairs from New York University.